Marchesi Antonella, Silva Jessica A, Wiese Birgitt, Nader-Macías María E F
CERELA-CONICET, Chacabuco 145, Tucuman, Argentina.
Hannover Medical School, Carl-Neuberg-Str.1, 30625 Hannover, Germany.
Curr Pharm Des. 2020;26(29):3608-3618. doi: 10.2174/1381612826666200218093607.
Lactobacilli are the dominant bacteria in the healthy vaginal tract, preventing the income of pathogenic microorganisms, either sexually or not transmitted. Probiotics are used to restore the vaginal microbiome by local administration. However, the ascendant colonization is proposed as a way to restore the vaginal balance, and to exert some complementary effects on the host, situation that requires that probiotic strains resist the gastrointestinal tract passage.
To determine which probiotic vaginal strains were able to resist different gastrointestinal factors (pH, bile salts, and enzymes) to advance in the design of oral formulas.
Different protocols were applied to evaluate the growth of 24 beneficial vaginal lactic bacteria (BVL) strains at low pH and high bile salts (individually evaluated) and in combined protocols. The viability of the strains in simulated gastrointestinal tract conditions was studied to select the most resistant strains.
A low number of BVL was able to grow at low pH. Most of the strains did not survive at high bile salts concentration. The passage through pH first and bile salts later showed that only three strains were able to survive. In the simulated intestinal conditions, only Lactobacillus gasseri CRL1290, L. jensenii CRL1313, and L. jensenii CRL1349 decrease one or two logarithmic growth units (UFC/ml) at the end of the assay, maintaining their beneficial properties.
The behavior of BVL in the conditions assayed is not related to specific strain or metabolic group, because the resistance is strain-specific. The results highlight the importance of the screening performed in a way to select the most adequate strains to be included in the oral designed formula for the restoration of the vaginal tract microbiome.
乳酸杆菌是健康阴道中的主要细菌,可防止致病微生物通过性传播或非性传播进入。益生菌通过局部给药用于恢复阴道微生物群。然而,优势定殖被认为是恢复阴道平衡并对宿主发挥一些补充作用的一种方式,这种情况要求益生菌菌株能够抵抗胃肠道的通过。
确定哪些益生菌阴道菌株能够抵抗不同的胃肠道因素(pH值、胆盐和酶),以推进口服配方的设计。
应用不同的方案评估24株有益阴道乳酸菌(BVL)在低pH值和高胆盐(单独评估)以及联合方案下的生长情况。研究了这些菌株在模拟胃肠道条件下的活力,以选择最具抗性的菌株。
少数BVL能够在低pH值下生长。大多数菌株在高胆盐浓度下无法存活。先经过pH值处理再经过胆盐处理表明只有三株菌株能够存活。在模拟肠道条件下,只有加氏乳杆菌CRL1290、詹氏乳杆菌CRL1313和詹氏乳杆菌CRL1349在试验结束时减少了一到两个对数生长单位(CFU/ml),并保持其有益特性。
在测定条件下BVL的行为与特定菌株或代谢组无关,因为抗性是菌株特异性的。结果强调了进行筛选以选择最适合纳入口服设计配方以恢复阴道微生物群的菌株的重要性。